Related references
Note: Only part of the references are listed.Mutation of the RelA(p65) Thr505 phosphosite disrupts the DNA replication stress response leading to CHK1 inhibitor resistance
Jill E. Hunter et al.
BIOCHEMICAL JOURNAL (2022)
Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway
Jill E. Hunter et al.
BIOCHEMICAL JOURNAL (2022)
Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells
Xingyi Kuang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation
Dana Goldbraikh et al.
EMBO REPORTS (2020)
ERK/MAPK signalling pathway and tumorigenesis
Yan-Jun Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics
Dominic P. Byrne et al.
BIOCHEMICAL JOURNAL (2020)
Claspin - checkpoint adaptor and DNA replication factor
Veronique A. J. Smits et al.
FEBS JOURNAL (2019)
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
Elaine Y. Chung et al.
CLINICAL CANCER RESEARCH (2019)
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death
Anne M. van Harten et al.
ONCOGENESIS (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus
Mike Flint et al.
NATURE COMMUNICATIONS (2019)
USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors
Kah Suan Lim et al.
MOLECULAR CELL (2018)
Evaluation of Parameters for Confident Phosphorylation Site Localization Using an Orbitrap Fusion Tribrid Mass Spectrometer
Samantha Ferries et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy
Laura Carrassa et al.
CANCER TREATMENT REVIEWS (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma
J. E. Hunter et al.
ONCOGENE (2016)
The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma
Mike I. Walton et al.
ONCOTARGET (2016)
A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase
Nandini Sakurikar et al.
ONCOTARGET (2016)
Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer
Gary Beale et al.
BRITISH JOURNAL OF CANCER (2016)
FANCI is a negative regulator of Akt activation
Xiaoshan Zhang et al.
CELL CYCLE (2016)
Mutations specific to the Rac-GEF domain of TRIO cause intellectual disability and microcephaly
Reuben J. Pengelly et al.
JOURNAL OF MEDICAL GENETICS (2016)
A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancer
A. Moles et al.
ONCOGENE (2016)
Evaluating Multiplexed Quantitative Phosphopeptide Analysis on a Hybrid Quadrupole Mass Filter/Linear Ion Trap/Orbitrap Mass Spectrometer
Brian K. Erickson et al.
ANALYTICAL CHEMISTRY (2015)
Myc induced replicative stress response: How to cope with it and exploit it
Sara Rohban et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
S-phase-dependent p50/NF-κB1 phosphorylation in response to ATR and replication stress acts to maintain genomic stability
Clayton D. Crawley et al.
CELL CYCLE (2015)
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736
Valentina Restelli et al.
ONCOTARGET (2015)
Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress
Apolinar Maya-Mendoza et al.
MOLECULAR ONCOLOGY (2015)
On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities
Yufeng Wei
PHARMACEUTICALS (2015)
Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies
Christine M. Lovly et al.
CLINICAL CANCER RESEARCH (2014)
Causes and consequences of replication stress
Michelle K. Zeman et al.
NATURE CELL BIOLOGY (2014)
Pak2 is required for actin cytoskeleton remodeling, TCR signaling, and normal thymocyte development and maturation
Hyewon Phee et al.
ELIFE (2014)
Targeting PI3K/Akt/mTOR signaling in cancer
Camillo Porta et al.
FRONTIERS IN ONCOLOGY (2014)
The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
Juan Antonio Vizcaino et al.
NUCLEIC ACIDS RESEARCH (2013)
A potent Chkl inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress
K. Brooks et al.
ONCOGENE (2013)
Mechanisms of replication fork protection: a safeguard for genome stability
Alessia Errico et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
Hyungjin Kim et al.
GENES & DEVELOPMENT (2012)
USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells
Zhang Zhiqiang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
P. T. Ferrao et al.
ONCOGENE (2012)
The Mre11 Nuclease Is Critical for the Sensitivity of Cells to Chk1 Inhibition
Ruth Thompson et al.
PLOS ONE (2012)
ERK1/2 MAP kinases: Structure, function, and regulation
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2012)
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
Ryohei Katayama et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance
Stefano Campaner et al.
CELL DIVISION (2012)
HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR-Mutant Lung Cancers That Lack the Second-Site EGFRT790M Mutation
Ken Takezawa et al.
CANCER DISCOVERY (2012)
USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
Jean-Hugues Guervilly et al.
HUMAN MOLECULAR GENETICS (2011)
Universal and Confident Phosphorylation Site Localization Using phosphoRS
Thomas Taus et al.
JOURNAL OF PROTEOME RESEARCH (2011)
MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics
Lily Ting et al.
NATURE METHODS (2011)
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
Matilde Murga et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
Kristina A. Cole et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Neuronal Growth Cone Retraction Relies on Proneurotrophin Receptor Signaling Through Rac
Katrin Deinhardt et al.
SCIENCE SIGNALING (2011)
Anticancer therapy with checkpoint inhibitors: what, where and when?
Michelle D. Garrett et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Mechanisms and functions of p38 MAPK signalling
Ana Cuadrado et al.
BIOCHEMICAL JOURNAL (2010)
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
Jessie Villanueva et al.
CANCER CELL (2010)
Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1
Emmani B. M. Nascimento et al.
CELLULAR SIGNALLING (2010)
IKK and NF-κB-mediated regulation of Claspin impacts on ATR checkpoint function
Niall Steven Kenneth et al.
EMBO JOURNAL (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
Constitutive Activation of the DNA Damage Signaling Pathway in Acute Myeloid Leukemia with Complex Karyotype: Potential Importance for Checkpoint Targeting Therapy
Cindy Cavelier et al.
CANCER RESEARCH (2009)
Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941
Florence I. Raynaud et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms
Salvatore J. Coniglio et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
DNA replication stress, genome instability and aging
William C. Burhans et al.
NUCLEIC ACIDS RESEARCH (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Regulation of DNA repair by ubiquitylation
TT Huang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD
H Renganathan et al.
BIOCHEMICAL JOURNAL (2005)
Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation
J Krueger et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
S Rocha et al.
EMBO JOURNAL (2005)
PAK and other Rho-associated kinases - effectors with surprisingly diverse mechanisms of regulation
ZS Zhao et al.
BIOCHEMICAL JOURNAL (2005)
Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation
P Viatour et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase
N Machida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB
KJ Campbell et al.
MOLECULAR CELL (2004)
The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression
ME Minard et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias
NP Shah et al.
ONCOGENE (2003)
Heat shock protein 27 controls apoptosis by regulating Akt activation
MJ Rane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action
A Trencia et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3
MC Wilkes et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The mechanism of PAK activation - Autophosphorylation events in both regulatory and kinase domains control activity
C Chong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The Rac1-and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin
JM Bellanger et al.
NATURE CELL BIOLOGY (2000)
Share Paper
